Cohance Lifesciences Limited
COHANCE
株式のランク
#6385
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
株価
$5.05
最終同期: 2026-10-19
時価総額
$1.93B
変化（1日）
-1.44%
変化（1年）
-57.38%
国
IN
取引 Cohance Lifesciences Limited (COHANCE)
カテゴリー
Healthcare
Cohance Lifesciences Limited（COHANCE）のP/S比率
October 2026 時点のP/S比率 TTM: 75.08
Cohance Lifesciences Limited の最新の財務報告および株価によると、現在のP/S比率（TTM）は 75.08 です。2024 年末時点でのP/S比率は 16.21 でした。
Cohance Lifesciences Limited の P/S 比率の履歴（2019 ～ 2026）
各年末時点のP/S比率
| 年 | P/S比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 75.08 | 232.64% |
| 2025 | 22.57 | 39.25% |
| 2024 | 16.21 | 80.67% |
| 2023 | 8.97 | -26.49% |
| 2022 | 12.21 | -5.42% |
| 2021 | 12.91 | 306.97% |
| 2020 | 3.17 | -72.93% |
| 2019 | 11.71 | 0.00% |
同業他社のP/S比率
| 企業 | P/S比率 | P/S比率の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -90.60% |
IN
|
